These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 101007)

  • 21. Comparison of the concentrations of glutathione and of iodine-reducing substances in human erythrocytes.
    Jesenovec N; Fiser-Herman M
    Clin Chim Acta; 1966 Sep; 14(3):293-9. PubMed ID: 5230220
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythrocyte density distribution in sickle cell anemia.
    Weems HB; Lessin LS
    Acta Haematol; 1984; 71(6):361-70. PubMed ID: 6433616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG; Miller DR; Cerami A; Manning JM
    J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of plasma and red cell factors on the rheologic properties of oxygenated sickle blood during clinical steady state.
    Morris CL; Gruppo RA; Shukla R; Rucknagel DL
    J Lab Clin Med; 1991 Oct; 118(4):332-42. PubMed ID: 1940575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrocyte pyruvate kinase activation in red cell disorders.
    Matte A; Federti E; De Franceschi L
    Curr Opin Hematol; 2023 May; 30(3):93-98. PubMed ID: 36853806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of irreversibly sickled cells in reducing the osmotic fragility of red cells in sickle cell anemia.
    Figueiredo MS; Zago MA
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):49-56. PubMed ID: 2932889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heme synthesis in hereditary hemolytic anemias: decreased delta-aminolevulinic acid synthetase in hemoglobin Köln disease.
    Kolski GB; Miller DR
    Pediatr Res; 1976 Jul; 10(7):702-6. PubMed ID: 934737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reduced deformability of erythrocytes as a common denominator of hemolytic anemias].
    Tillmann W
    Wien Med Wochenschr; 1986; 136 Spec No():14-6. PubMed ID: 3548086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An automated method of differential red blood cell classification with application to the diagnosis of anemia.
    Bacus JW; Weens JH
    J Histochem Cytochem; 1977 Jul; 25(7):614-32. PubMed ID: 330716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary disorders of the erythrocyte.
    Crowley C; Necheles TF
    Clin Perinatol; 1976 Mar; 3(1):161-75. PubMed ID: 782768
    [No Abstract]   [Full Text] [Related]  

  • 32. Beyond adenosine triphosphate: unveiling the pleiotropic effects of pyruvate kinase activation in sickle cell anemia.
    Glenthøj A
    Haematologica; 2024 Aug; 109(8):2398-2400. PubMed ID: 38634127
    [No Abstract]   [Full Text] [Related]  

  • 33. Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.
    Zarza R; Moscardó M; Alvarez R; García J; Morey M; Pujades A; Vives-Corrons JL
    Haematologica; 2000 Mar; 85(3):227-32. PubMed ID: 10702808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anomalous cell surface structure of sickle cell anemia erythrocytes as demonstrated by cell surface labeling and endo-beta-galactosidase treatment.
    Fukuda M; Fukuda MN; Hakomori S; Papayannopoulou T
    J Supramol Struct Cell Biochem; 1981; 17(3):289-97. PubMed ID: 6799655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophoretic studies of sickle cell anemia.
    STEPHENSON EE
    Am J Med Technol; 1956 Dec; 22(6a):61-4. PubMed ID: 13372555
    [No Abstract]   [Full Text] [Related]  

  • 36. Red cell distribution width in sickle cell disease.
    Webster P; Castro O
    Ann Clin Lab Sci; 1986; 16(4):274-7. PubMed ID: 3740796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The coincidence of sickle cell trait and pernicious anemia; report of a case.
    FUSCO FA; BOURONCLE BA
    Acta Haematol; 1958 Dec; 20(6):383-6. PubMed ID: 13616936
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sideroblasts in acquired sideroblastic anemia and various hematological syndromes].
    Gepner-Woźniewska M; Nowak S
    Acta Haematol Pol; 1972; 3(3):219-27. PubMed ID: 4649305
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of cyanate on red blood cell sickling.
    Cerami A; Manning JM; Gillette PN; De Furia F; Miller D; Graziano JH; Peterson CM
    Fed Proc; 1973 Jun; 32(6):1668-72. PubMed ID: 4268029
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of pyruvate kinase activators on red blood cell properties in sickle cell disease.
    Joly P; Nader E; Ketels F; Boisson C; Carin R; Renoux C; Gauthier A; Poutrel S; Bertrand Y; Connes P
    Br J Haematol; 2023 Aug; 202(4):e27-e30. PubMed ID: 37278058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.